Complex Regional Pain Syndrome (CRPS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Complex regional pain syndrome (CRPS), or Sudeck's dystrophy or reflex sympathetic dystrophy, is a painful condition characterized by various symptoms, including pain, sensory disturbances, Sudo- and vasomotor abnormalities, trophic changes, and impaired motor function. CRPS can develop due to different levels or types of tissue damage. In some cases, it has even been observed without any injury, often arising from extended periods of immobilization. Among the most common causes of CRPS is a fracture, while surgery is another frequent trigger. Other injuries or insults that can incite CRPS encompass sprains, contusions, crush injuries, and surgical procedures. CRPS is categorized into two main types: type I, formerly known as reflex sympathetic dystrophy, and type II, previously termed causalgia. Type I occurs without associated nerve trauma, whereas type II arises following known nerve injuries. Additionally, CRPS is further subdivided into "warm" versus "cold" varieties, and sympathetically-maintained (SMP) versus sympathetically-independent (SIP) forms, which can influence both the prognosis and available treatment options. Patients with CRPS receive treatment from a diverse range of medical specialists, including anaesthesiologists, (orthopaedic) surgeons, neurologists, rheumatologists, and rehabilitation centers, due to the multifaceted nature of the condition and its wide array of symptoms. It's important to note that there are currently no medications approved by the Food and Drug Administration (FDA) specifically for treating CRPS. Consequently, treatment protocols frequently require the use of off-label medications. Limitations in available medications could potentially restrict options for both healthcare providers and patients in managing their symptoms. The prognosis of CRPS varies, with instances of spontaneous remission and refractory clinical presentations observed. However, early intervention may lead to improved outcomes. Long-standing CRPS can be associated with complications such as dystonia, cognitive executive dysfunction, adrenal insufficiency, gastroparesis, and irritable bowel syndrome.

·       The prevalence of CRPS varied between 7.68 and 27.1 cases per 100,000 population.

 

Thelansis’s “Complex Regional Pain Syndrome (CRPS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Complex Regional Pain Syndrome (CRPS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

 

KOLs insights of Complex Regional Pain Syndrome (CRPS) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Complex Regional Pain Syndrome (CRPS) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Complex Regional Pain Syndrome (CRPS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Tags: Complex Regional Pain Syndrome (CRPS), Complex Regional Pain Syndrome (CRPS) market outlook, Complex Regional Pain Syndrome (CRPS) competitive landscape, Complex Regional Pain Syndrome (CRPS) market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)

 

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Herpes Simplex Virus (HSV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Herpes simplex virus (HSV) causes an infection that affects the external genitalia, anal region, mucosal surfaces, and skin in other body parts. Herpes simplex virus is a ubiquitous, host-adapted pathogen that causes various disease states. There are two types of HSV with two distinct DNA viruses, type 1 (HSV-1) and type 2 (HSV-2). Both the types are closely related but differ epidemiologically. HSV-1 is traditionally associated with orofacial disease by affecting the mouth and lips with fever blisters and cold sores, whereas HSV-2 is associated traditionally with genital disease infecting genitals and rectum area with sores and is classified as STD (sexually transmitted disease). As HSV-1 is associated with genital infections more often than HSV-2, lesion location is not necessarily of viral type. HSV can spread through direct contact. Almost 80% of Herpes simplex infections are asymptomatic, while symptomatic infections can be characterized by significant morbidity and recurrenc...
Read more

HR+/HER2- Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
Thelansis’s “HR+/HER2- Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HR+/HER2- Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of HR+/HER2- Breast Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. HR+/HER2- Breast Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model,...
Read more